Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Celularity Inc (CELU)

Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
Celularity Inc. Regains Nasdaq Compliance Following Successful Filing of Quarterly Report

Celularity Inc. has regained compliance with Nasdaq regulations, resolving prior filing delays and improving financial reporting processes.Quiver AI SummaryCelularity Inc. announced it has regained compliance...

CELU : 1.5550 (-5.18%)
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
Celularity Inc. Files Current Quarterly Report, Reports Significant Revenue Growth for Q3 2024

Celularity reported significant revenue growth for Q3 2024, filing its Form 10-Q and meeting Nasdaq compliance requirements.Quiver AI SummaryCelularity Inc. has filed its Quarterly Report on Form 10-Q...

CELU : 1.5550 (-5.18%)
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

CELU : 1.5550 (-5.18%)
CELUW : 0.0400 (+0.25%)
Celularity Inc. Receives Nasdaq Notice for Non-Compliance with Continued Listing Requirements

Celularity Inc. faces Nasdaq non-compliance but plans to submit a compliance plan by January 20, 2025.Quiver AI SummaryCelularity Inc., a regenerative medicine company, announced on November 21, 2024,...

CELU : 1.5550 (-5.18%)

Barchart Exclusives

1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’
One Wall Street analyst is backing up Cathie Wood’s view that DraftKings is a stock to buy in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar